Cytotoxic Effect of Thymoquinone-Loaded Nanostructured Lipid Carrier (TQ-NLC) on Liver Cancer Cell Integrated with Hepatitis B Genome, Hep3B

Table 2

Percentage of viable, apoptotic, and necrotic Hep3B as determined by flow cytometer.

	Percentage of cell
	Viable Cell	Early apoptosis	Late apoptosis	Necrosis
UNTREATED	89.1 ± 0.8	4.3 ± 0.7	3.7 ± 0.1	2.9 ± 1.1
NLC	88.9 ± 2.8	3.9 ± 1.1	2.5 ± 1.1	4.7 ± 2.0
TQ (24 hours)	84.5 ± 0.9	6.0 ± 1.4	6.9 ± 0.5	2.6 ± 0.4
TQ (48 hours)	83.4 ± 0.4	7.1 ± 1.3	6.0 ± 0.9	3.4 ± 0.3
TQ (72 hours)	82.0 ± 3.3	7.1 ± 0.9	6.4 ± 0.5	4.5 ± 1.2
TQ-NLC (24 hours)	81.1 ± 1.3	6.7 ± 1.6	6.0 ± 0.7	6.2 ± 2.5
TQ-NLC (48 hours)	79.8 ± 3.2	6.9 ± 1.3	7.7 ± 0.7	5.6 ± 0.9
TQ-NLC (72 hours)	78.2 ± 2.0	9.3 ± 0.5	8.0 ± 1.4	4.7 ± 0.6

Each data point represents the mean of three independent experiments. Each value was represented as a mean ±SEM.